Papers
3
Total Citations
503
H-Index
3
About
Eric Tran is a leading clinical researcher in head and neck oncology, best known for his pivotal work comparing treatment modalities for oropharyngeal squamous cell carcinoma (OPSCC). His primary research areas include radiotherapy, transoral robotic surgery (TORS), and the management of HPV-related oropharyngeal cancers. Tran’s major contribution is the ORATOR trial, a landmark phase II randomized study that directly compared radiotherapy versus TORS with neck dissection for early-stage OPSCC. The initial results, published in 2019 and cited over 458 times, provided critical evidence on swallowing outcomes and survival between these two curative-intent approaches. The final five-year outcomes, reported in 2024, further solidified the trial’s impact by offering mature data on long-term efficacy and toxicity. This work has been instrumental in guiding treatment decisions for a disease whose incidence has surged due to the HPV epidemic. By challenging assumptions that TORS was superior, Tran’s research has shaped clinical practice and sparked ongoing debate in the field. His contributions are essential reading for any clinician or researcher navigating the evolving landscape of oropharyngeal cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3